This inventor holds 25 USPTO granted patents and 10 published patent applications, plus 7 CIPO patents and 7 EPO patents. Top assignees: Pfizer Corporation, The University of British Columbia, Centre for Drug Research and Development. Active years: 2015-2026.
Location History:
- Burnaby, CA (2016)
- Cambridge, MA (US) (2017)
- Tappan, NY (US) (2015 - 2024)
Company Filing History:
18 out of 4,486 
6 out of 959 
4 out of 5 
Years Active: 2015-2026
Title: The Innovative Mind of Rajesh Kumar Kainthan
Introduction: Rajesh Kumar Kainthan, based in Tappan, NY, is a notable inventor with a remarkable portfolio of 22 patents. His groundbreaking work predominantly focuses on immunogenic compositions and glycoconjugation processes, demonstrating his commitment to advancing medical science and public health.
Latest Patents: Among his latest innovations is a patent for the "Glycoconjugation process," which involves methods for preparing glycoconjugates that combine saccharides with carrier proteins using stable nitroxyl radicals as oxidizing agents. This patent contributes to the development of immunogenic compositions featuring glycoconjugates for potential use in vaccines. Another significant patent is for "Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof." This invention introduces novel immunogenic compositions that contain glycoconjugates from serotypes not included in existing vaccines such as PREVNAR® and SYNFLORIX®, thus broadening the possibilities for vaccination against pneumococcal infections in vulnerable populations including infants and the elderly.
Career Highlights: Rajesh has had an illustrious career, having worked with prominent organizations such as Pfizer Corporation and the University of British Columbia. His experience at these institutions has significantly contributed to his expertise in research and innovation in the field of immunology.
Collaborations: Throughout his career, Rajesh Kumar Kainthan has collaborated with talented individuals, including Avvari Krishna Prasad and Jin-Hwan Kim. These collaborations reflect a collective effort towards advancing research and creating impactful innovations in health sciences.
Conclusion: Rajesh Kumar Kainthan stands out in the realm of invention with his substantial contributions to immunology and vaccine development. His innovative patents are poised to play a pivotal role in enhancing public health initiatives and combating infectious diseases.